Senior insider sale
General Counsel at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$482.3K
1.30K shares
What this filing means
KELLEY SHANNON T plans to sell 1.30K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $482.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2025ACC: 0002034056-25-000007
Officer· General Counsel
Since Mar 2026
1.30K
Shares to sell
$482.3K
Approx. market value
1.30K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
8/15/2025
846.00Restricted Stock Unit Grant
Vesting of Restricted Stock Units
8/15/2025
458.00Total acquired1.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2025 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 846.00 | — |
8/15/2025 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 458.00 | — |
| Total | 1.30K | ||
Planned & Completed Dispositions2
Nasdaq Stock MarketPlanned
Units to sell
458.00
Market value
$169.4K
8/18/2025
Nasdaq Stock MarketPlanned
Units to sell
846.00
Market value
$312.9K
8/18/2025
Total
Units
1.30K
Value
$482.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2025 | 458.00 | $169.4K | Nasdaq Stock Market | Planned |
8/18/2025 | 846.00 | $312.9K | Nasdaq Stock Market | Planned |
| Total | 1.30K | $482.3K | ||